1. Home
  2. NSPR vs SLND Comparison

NSPR vs SLND Comparison

Compare NSPR & SLND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo InspireMD Inc.

NSPR

InspireMD Inc.

HOLD

Current Price

$1.20

Market Cap

72.1M

Sector

Health Care

ML Signal

HOLD

Logo Southland Holdings Inc.

SLND

Southland Holdings Inc.

HOLD

Current Price

$1.08

Market Cap

64.0M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
NSPR
SLND
Founded
2005
1900
Country
United States
United States
Employees
N/A
1800
Industry
Medical/Dental Instruments
Military/Government/Technical
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
72.1M
64.0M
IPO Year
2009
N/A

Fundamental Metrics

Financial Performance
Metric
NSPR
SLND
Price
$1.20
$1.08
Analyst Decision
Buy
Hold
Analyst Count
1
1
Target Price
$4.00
$4.00
AVG Volume (30 Days)
55.0K
83.3K
Earning Date
05-04-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,310,000.00
N/A
Revenue This Year
$57.98
N/A
Revenue Next Year
$95.41
$9.59
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.12
$0.65
52 Week High
$2.93
$5.34

Technical Indicators

Market Signals
Indicator
NSPR
SLND
Relative Strength Index (RSI) 27.44 47.02
Support Level N/A $1.00
Resistance Level $2.47 $1.80
Average True Range (ATR) 0.09 0.09
MACD -0.00 0.01
Stochastic Oscillator 34.22 41.15

Price Performance

Historical Comparison
NSPR
SLND

About NSPR InspireMD Inc.

InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.

About SLND Southland Holdings Inc.

Southland Holdings Inc is an infrastructure construction company in North America. The company's infrastructure projects range from water conveyance systems and tunnels to long-span bridges and vertical structures. The company operates in two distinct segments: Civil and Transportation. The civil segment operates throughout North America and specializes in services that include the design and construction of water pipelines, pump stations, lift stations, water and wastewater treatment plants, concrete and structural steel, outfall, and tunneling. The transportation segment operates throughout North America and specializes in services that include the design and construction of bridges, roadways, marine, dredging, ship terminals and piers, and specialty structures and facilities.

Share on Social Networks: